Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression
Immunity, Inflammation and Disease · 2026-03 · 14 (3)
DOI: 10.1002/iid3.70411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 23.03.2026. Verfasst von Ali Afrasiabi und 9 weiteren Autor:innen. Beteiligte Einrichtung: EBV Molecular Lab, Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales…. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, B-Lymphocytes, Lupus Erythematosus, Systemic, Virus Latency. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multiple Sclerosis Research Australia, Medical Research Council, Australian Government Research Training Program.
Abstract (Originalsprache)
Epstein‐Barr virus (EBV) is an important environmental risk factor in the development of several autoimmune conditions, with the mechanisms still to be fully elucidated. EBV primarily infects memory B cells, transitioning between lytic (active) and latent (dormant) phases of infection. Our group has previously proposed two molecular mechanisms linking EBV pathogenesis to autoimmunity: one indicates that EBV lytic switching contributes to systemic lupus erythematosus (SLE) pathogenesis, while another posits that latency III is more crucial in the development of multiple sclerosis (MS). In this study, we tested the proposed molecular model using a cohort of EBV‐transformed lymphoblastoid cell lines derived from individuals with either SLE, MS or healthy controls. Measuring the expression levels of a panel of EBV genes, representing the different phases of the EBV lifecycle, we found compelling proof‐of‐concept evidence validating our proposed model. This discovery highlights promising signatures for further investigation, where the same approach can be explored across other EBV‐associated immune conditions, deepening our understanding of the virus's lifecycle dysregulation in autoimmunity etiology and ultimately aiding in the design of new treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- EBV Molecular Lab, Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
- Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, New South Wales, Australia.
- School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, New South Wales, Australia.
- COVID-19 Research Lab, Centre for Virology Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
- Department of Clinical Immunology and Allergy, Westmead Hospital and Institute of Clinical Pathology & Medical Research (ICPMR), Westmead, New South Wales, Australia.
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
ORCID-Profile: Grant P Parnell
Förderung
- Multiple Sclerosis Research Australia
- Medical Research Council
- Australian Government Research Training Program
Zitieren
APA
Afrasiabi, A., Bocking, W. J., Schibeci, S. D., Law, S. P. L., Fewings, N. L., Lin, M. W., Sawcer, S. J., Ban, M., Swaminathan, S., & Parnell, G. P. (2026). Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70411
Vancouver
Afrasiabi A, Bocking WJ, Schibeci SD, Law SPL, Fewings NL, Lin MW, et al. Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70411
BibTeX
@article{Afrasiabi2026,
author = {Afrasiabi, Ali and Bocking, Wade J and Schibeci, Stephen D and Law, Samantha P L and Fewings, Nicole L and Lin, Ming-Wei and Sawcer, Stephen J and Ban, Maria and Swaminathan, Sanjay and Parnell, Grant P},
title = {Epstein‐Barr Virus Transformed B Cells From Systemic Lupus Erythematosus and Multiple Sclerosis Patients Differ in EBV Lytic and Latency Marker Expression},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/iid3.70411}
}
EUVIMED